PubRank

C Szabo

Author PubWeight™ 45.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Growth retardation and tumour inhibition by BRCA1. Nat Genet 1996 3.47
2 A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 1997 2.01
3 Rapid 'glycaemic swings' induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus. Diabetologia 2009 1.75
4 Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int J Cancer 2000 1.51
5 Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc Natl Acad Sci U S A 2000 1.34
6 Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 2000 1.27
7 Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet 2001 1.26
8 Regulation of bacteriophage T5 development by ColI factors. J Virol 1972 1.25
9 Role of nitric oxide in vascular permeability after combined burns and smoke inhalation injury. Am J Respir Crit Care Med 2001 1.14
10 Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer 2012 1.12
11 The regulation of transcription in bacteriophage T5-infected Escherichia coli. Biochemistry 1975 1.10
12 Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 1999 1.09
13 Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability. Biochem Biophys Res Commun 1993 1.07
14 Inosine reduces inflammation and improves survival in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2002 1.02
15 Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine. Cancer Res 1994 1.01
16 Modulation of tendon healing by nitric oxide. Inflamm Res 1997 0.99
17 Purification and properties of a bacteriophage T5-modified form of Escherichia coli RNA polymerase. J Virol 1975 0.99
18 Nitric oxide in skeletal muscle: inhibition of nitric oxide synthase inhibits walking speed in rats. Nitric Oxide 2001 0.98
19 Solvent-depleted bilayer membrane from concentrated lipid solutions. Nature 1978 0.95
20 Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats. Curr Eye Res 2004 0.93
21 Complement component C3 production in IL-1beta-stimulated human intestinal epithelial cells is blocked by NF-kappaB inhibitors and by transfection with ser 32/36 mutant IkappaBalpha. J Surg Res 1999 0.93
22 Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies. Diabetologia 2009 0.91
23 Inhibition of infectious Rous sarcoma virus production by rifamycin derivative. J Virol 1976 0.89
24 Role of nitric oxide in myocardial dysfunction after combined burn and smoke inhalation injury. Burns 2001 0.88
25 Nitric oxide: an important articular free radical. J Bone Joint Surg Am 1996 0.88
26 Immunohistochemical localization of protein 3-nitrotyrosine and S-nitrosocysteine in a murine model of inhaled nitric oxide therapy. Pediatr Res 2000 0.88
27 Evidence for a BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet 1999 0.86
28 Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice. Exp Neurol 2001 0.85
29 5-aminosalicylic acid inhibits iNOS transcription in human intestinal epithelial cells. Int J Mol Med 1999 0.84
30 Modification of metabolism of transplantable and spontaneous murine tumors by the nitric oxide synthase inhibitor, nitro-L-arginine. Int J Radiat Oncol Biol Phys 1994 0.84
31 Activated neutrophils inhibit cerebrovascular endothelium-dependent relaxations in vitro. Life Sci 1991 0.82
32 Effects of nicaraven on nitric oxide-related pathways and in shock and inflammation. Shock 2000 0.81
33 Traumatic brain injury in mice deficient in poly-ADP(ribose) polymerase: a preliminary report. Acta Neurochir Suppl 2000 0.81
34 Progesterone inhibits inducible nitric oxide synthase mRNA expression in human intestinal epithelial cells. Int J Mol Med 2000 0.81
35 Depression of the inotropic action of isoprenaline by nitric oxide synthase induction in rat isolated hearts. Eur J Pharmacol 1997 0.80
36 Antiviral action of a rifamycin derivative: formation Rous sarcoma virus particles deficient in 60 to 70S RNA. J Virol 1978 0.80
37 Mitogen-activated protein kinase phosphorylation in kidneys of beta(s) sickle cell mice. J Am Soc Nephrol 2000 0.79
38 Complement C3 production in human intestinal epithelial cells is regulated by interleukin 1beta and tumor necrosis factor alpha. Arch Surg 1997 0.78
39 Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys. Kidney Int 2000 0.78
40 Potent inhibition of the inducible isoform of nitric oxide synthase by aminoethylisoselenourea and related compounds. Life Sci 1996 0.77
41 S-substituted isothioureas are potent inhibitors of nitric oxide biosynthesis in cartilage. Eur J Pharmacol 1996 0.77
42 Isoflavone-mediated inhibition of tyrosine kinase: a novel antiinflammatory approach. J Med Food 1999 0.76
43 Changes in energy metabolism and X-ray sensitivity in murine tumours by the nitric oxide donor SIN-1. Br J Cancer Suppl 1996 0.75
44 Nitric oxide and sepsis. JAMA 1996 0.75
45 Regional differences in the regulation of contraction-relaxation machinery of vascular smooth muscle. Adv Exp Med Biol 1989 0.75
46 Mechanism of hemoglobin-induced spasm in the isolated middle cerebral artery of the cat. Adv Exp Med Biol 1989 0.75